Now Is The Time To Build A Position In Silexion Therapeutics Corp (NASDAQ:SLXN)
In last trading session, Silexion Therapeutics Corp (NASDAQ:SLXN) saw 0.41 million shares changing hands with its beta currently measuring 0.08. Company’s recent per share price